BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 30530603)

  • 1. The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates
    Wiederhold NP; Lockhart SR; Najvar LK; Berkow EL; Jaramillo R; Olivo M; Garvey EP; Yates CM; Schotzinger RJ; Catano G; Patterson TF
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30530603
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis.
    Wiederhold NP; Najvar LK; Shaw KJ; Jaramillo R; Patterson H; Olivo M; Catano G; Patterson TF
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibrexafungerp Demonstrates
    Wiederhold NP; Najvar LK; Olivo M; Morris KN; Patterson HP; Catano G; Patterson TF
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33753333
    [No Abstract]   [Full Text] [Related]  

  • 4. The Novel Arylamidine T-2307 Demonstrates
    Wiederhold NP; Najvar LK; Jaramillo R; Olivo M; Patterson H; Connell A; Fukuda Y; Mitsuyama J; Catano G; Patterson TF
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fungal Cyp51 Inhibitor VT-1129 Is Efficacious in an Experimental Model of Cryptococcal Meningitis.
    Wiederhold NP; Najvar LK; Garvey EP; Brand SR; Xu X; Ottinger EA; Alimardanov A; Cradock J; Behnke M; Hoekstra WJ; Schotzinger RJ; Jaramillo R; Olivo M; Kirkpatrick WR; Patterson TF
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel fungal CYP51 inhibitor VT-1598 displays classic dose-dependent antifungal activity in murine models of invasive aspergillosis.
    Garvey EP; Sharp AD; Warn PA; Yates CM; Atari M; Thomas S; Schotzinger RJ
    Med Mycol; 2020 Jun; 58(4):505-513. PubMed ID: 32476008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis.
    Wiederhold NP; Shubitz LF; Najvar LK; Jaramillo R; Olivo M; Catano G; Trinh HT; Yates CM; Schotzinger RJ; Garvey EP; Patterson TF
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida auris and multidrug resistance: Defining the new normal.
    Lockhart SR
    Fungal Genet Biol; 2019 Oct; 131():103243. PubMed ID: 31228646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
    Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasis.
    Garvey EP; Hoekstra WJ; Schotzinger RJ; Sobel JD; Lilly EA; Fidel PL
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5567-73. PubMed ID: 26124165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice.
    Break TJ; Desai JV; Healey KR; Natarajan M; Ferre EMN; Henderson C; Zelazny A; Siebenlist U; Yates CM; Cohen OJ; Schotzinger RJ; Perlin DS; Garvey EP; Lionakis MS
    J Antimicrob Chemother; 2018 Aug; 73(8):2089-2094. PubMed ID: 29788070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
    Lepak AJ; Zhao M; Berkow EL; Lockhart SR; Andes DR
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584152
    [No Abstract]   [Full Text] [Related]  

  • 13. Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of
    Vélez N; Argel A; Kissmann AK; Alpízar-Pedraza D; Escandón P; Rosenau F; Ständker L; Firacative C
    Front Cell Infect Microbiol; 2024; 14():1389020. PubMed ID: 38601736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus.
    Wiederhold NP; Patterson HP; Tran BH; Yates CM; Schotzinger RJ; Garvey EP
    J Antimicrob Chemother; 2018 Feb; 73(2):404-408. PubMed ID: 29190379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong
    Schell WA; Jones AM; Garvey EP; Hoekstra WJ; Schotzinger RJ; Alexander BD
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
    Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
    J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the
    Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F
    Microbiol Spectr; 2021 Dec; 9(3):e0139521. PubMed ID: 34730380
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Hager CL; Larkin EL; Long L; Zohra Abidi F; Shaw KJ; Ghannoum MA
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311065
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis.
    Gamal A; Long L; Herrada J; Aram J; McCormick TS; Ghannoum MA
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0054921. PubMed ID: 34228541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis.
    Garvey EP; Sharp AD; Warn PA; Yates CM; Schotzinger RJ
    J Antimicrob Chemother; 2018 Oct; 73(10):2815-2822. PubMed ID: 29947783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.